bromodeoxyuridine has been researched along with Adenocarcinoma in 135 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (20.00) | 18.7374 |
| 1990's | 62 (45.93) | 18.2507 |
| 2000's | 40 (29.63) | 29.6817 |
| 2010's | 6 (4.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bremus-Köbberling, E; Feher, K; Junge, K; Klink, CD; Lambertz, A; Neumann, UP; Pich, A; Röth, A; Schmitz, D | 1 |
| Febbo, PG; Finn, S; Fiore, C; Fiorentino, M; Fornari, A; Grisanzio, C; Hahn, WC; Inazuka, F; Kung, AL; Loda, M; Ma, J; Migita, T; Mucci, L; Palescandolo, E; Priolo, C; Ruiz, S; Shin, E; Signoretti, S; Stampfer, M; Subramanian, A; Xie, W; Zadra, G | 1 |
| Amm, HM; Frost, AR; Johnson, MR; Novak, Z; Steg, A | 1 |
| Bucki, K; Darasz, Z; Gasinska, A; Malecki, K; Niemiec, J; Richter, P; Sokolowski, A | 1 |
| Fahrig, R; Fahrig, T; Heinrich, JC; Schroeder, M; Tuukkanen, A | 1 |
| Jia, Q; Jiang, W; Liu, L; Ma, N; Tan, A; Zhang, H; Zhao, X | 1 |
| Murasaki, T; Nakanishi, M; Ogawa, K; Shirai, T; Sugiura, S | 1 |
| Barberi-Heyob, M; Didelot, C; Merlin, JL; Mirjolet, JF | 1 |
| Kanno, J; Mikami, T; Ohkusa, T; Okayasu, I; Yamada, M; Yoshida, T | 1 |
| Cutress, RI; Mullee, MA; Rew, DA | 1 |
| Knudsen, KE; Monk, KR; Petre, CE; Puga, A; Wetherill, YB | 1 |
| Cernaianu, G; Cetto, M; Falk, W; Geissler, EK; Guba, M; Jauch, KW; Köhl, G; Kunz-Schughart, LA; Steinbauer, M | 1 |
| Kawamori, T; Sugimura, T; Uchiya, N; Wakabayashi, K | 1 |
| Dellinger, RW; Karjian, PL; Neuteboom, ST | 1 |
| Chapman, W; Fykes, AW; Hill, RP; Juvet, S; Levin, W; Manchul, LA; Milosevic, M; Pintilie, M; Tsang, RW; Wong, CS | 1 |
| Ma, QY; Rowlands, BJ; Williamson, KE | 1 |
| Kitajima, M; Kubota, T; Kumai, K; Maeda, S; Otani, Y; Saikawa, Y | 1 |
| Jaiswal, K; Lopez-Guzman, C; Sarosi, GA; Souza, RF; Spechler, SJ | 1 |
| Fukami, H; Hirata, A; Sakai, H; Tatematsu, M; Tsukamoto, T | 1 |
| Dziegiel, P; Kanzawa, H; Madej, JA; Nowak, M | 1 |
| Costa, RH; Davidson, NO; Wang, IC; Yoder, HM; Yoshida, Y | 1 |
| Adamczyk, A; Biesaga, B; Bucki, K; Darasz, Z; Gasinska, A; Kowalska, T; Malecki, K; Niemiec, J; Nowak, K; Popiela, T; Reinfuss, M; Richter, P; Skolyszewski, J | 1 |
| Durham, LE; Gray, DR; Greenberg, NM; Huss, WJ; Johnson, MA; Marmillion, ME; Smith, GJ; Tavakoli, K | 1 |
| Chen, YJ; Kuo, CD; Liao, HF; Tsai, YM; Wang, GS; Yu, CC | 1 |
| Browne, W; Johnson, JB; Noguchi, PD | 1 |
| Kawai, K; Yamaguchi, N | 1 |
| Noordzij, MA; Oomen, MH; Schröder, FH; van der Kwast, TH; van Steenbrugge, GJ; van Weerden, WM | 1 |
| Siegfried, JM; Singh-Kaw, P; Zarnegar, R | 1 |
| Banerjee, D; Fyles, AW; Kirkbride, P; Levin, W; Manchul, LA; Milosevic, MF; Pintilie, M; Rawlings, GA; Tsang, RW; Wilson, GD | 1 |
| Chen, TH; Coffey, DS; Pasternack, GR; Walensky, LD; Wu, TC | 1 |
| Carroll, PR; Cher, ML; Chew, K; Rosenau, W | 1 |
| Bentzen, SM; Høyer, M; Overgaard, J; Salling, LN | 1 |
| Harada, T; Hayashi, S; Maita, K; Miyajima, H; Mori, I; Yoshida, A | 1 |
| Carroll, PR; Cohen, MB; Fong, P; Mayall, BH; Narayan, P; Rosenau, W; Vapnek, JM; Waldman, FM | 1 |
| Cheyer, C; O'Riordan, MA; Pretlow, TP | 1 |
| Halliday, MI; Hamilton, PW; Rowlands, BJ; Williamson, KE | 1 |
| Hakamada, K; Matsumoto, M; Suzuki, H; Tahara, E; Taniyama, K; Toyama, K | 1 |
| Chung, YS; Nakata, B; Sowa, M | 1 |
| Fukushima, S; Kurata, Y; Mizoguchi, M; Montesano, R; Naito, H; Shibata, MA; Tsuda, H; Wild, CP | 1 |
| Hosokawa, Y; Isetani, K; Kashima, K; Kodama, T; Maruyama, K; Mitsufuji, S; Tokita, K; Tsuchihashi, Y; Wakabayashi, N | 1 |
| Høyer, M; Overgaard, J; Salling, LN | 1 |
| Capizzi, RL; Fernandes, DJ; Wheeler, KT; Yang, JL | 1 |
| Baba, M; Iishi, H; Nakaizumi, A; Tatsuta, M; Uehara, H; Yano, H | 1 |
| Brugal, G | 1 |
| De Clercq, E; Hashimoto, K; Igarashi, A; Kodama, E; Mori, S; Shigeta, S; Suzuki, T | 1 |
| Beekhuis, JA; Dohle, GR; Schröder, FH; Tanke, HJ; van Steenbrugge, GJ | 1 |
| Fujimitsu, Y; Inada, K; Kobayashi, K; Nakanishi, H; Shirai, T; Tatematsu, M; Yamachika, T | 1 |
| Baldetorp, B; Bendahl, PO; Fadeel, IA; Johansson, MC; Oredsson, SM | 1 |
| Hashimoto, M; Morishita, S; Serda, D; Shimokawa, K; Takahashi, Y; Tamaya, T; Yokoyama, Y | 1 |
| Biesaga, B; Gasińska, A; Kolodziejski, L | 1 |
| Hodgkiss, RJ; Webster, L; Wilson, GD | 1 |
| Darlington, GJ; Finegold, MJ; Harrison, W; Hicks, MJ; Kang, DC; Soriano, HE; Wang, ND | 1 |
| Hood, CJ; Parham, DM | 1 |
| Wang, LD; Yang, CS; Zhou, Q | 1 |
| Wilson, GD | 1 |
| Anderson, BO; Creason, S; Hockenbery, D; Knowlton, K; Mancini, M; Morales, C | 1 |
| Reeve, LJ; Rew, DA; Wilson, GD | 1 |
| Hayashi, H; Ito, T; Kanisawa, M; Kitamura, H; Mitui, H; Okudela, K; Udaka, N | 1 |
| Friedrich, E; Hahn, EW; Klein, V; Peschke, P; Wolber, G | 1 |
| Chapman, W; Fyles, AW; Li, Y; Pintilie, M; Rajaraman, MM; Tsang, RW; Wong, CS | 1 |
| Ducrotté, P; Hemet, J; Lepessot, F; Mauillon, J; Michel, P; Paillot, B; Paresy, M; Peillon, C; Scotte, M; Seng, S | 1 |
| Esumi, H; Fukushima, S; Otori, K; Sugiyama, K | 1 |
| Eisbruch, A; Johnston, CM; Lawrence, TS; Reynolds, KR; Roberts, JA; Robertson, JM; Tworek, J | 1 |
| Fyles, AW; Levin, W; Manchul, LA; Milosevic, M; Pintilie, M; Syed, A; Tsang, RW | 1 |
| Baldetorp, B; Johansson, MC; Oredsson, SM | 1 |
| Ducrotté, P; Hellot, MF; Hemet, J; Lepessot, F; Michel, P; Paillot, B; Paresy, M; Peillon, C; Scotte, M | 1 |
| Adány, R; Balázs, M; Pásti, G; Sárváry, A; Tóth, L | 1 |
| Agbaria, R; Balzarini, J; Blaese, RM; Candotti, F; Johns, DG; Mullen, CA; Touraine, R | 1 |
| Baba, M; Iishi, H; Nakaizumi, A; Sakai, N; Tatsuta, M; Uehara, H; Yano, H | 1 |
| Egeli, U; Kizil, A; Tunca, B; Yerci, O; Yilmazlar, T; Zorluoglu, A | 1 |
| Fribourg, AF; Knudsen, ES; Knudsen, KE; Lindhorst, CM; Strobeck, MW | 1 |
| Meistrich, ML; Pollack, A; Terry, NH; White, RA | 1 |
| Johansson, M; Karlsson, A; Zheng, X | 1 |
| Ikeno, T; Ishida, K; Katsuyama, T; Kawasaki, S; Maruta, F; Murakami, M; Ota, H; Sugiyama, A; Tatematsu, M | 1 |
| Booth, E; Carnelley, T; Le, XC; Lee, J; Watson, WP; Weinfeld, M; Xing, JZ | 1 |
| Brown, WA; Malcontenti-Wilson, C; O'Brien, PE; Skinner, SA; Vogiagis, D | 1 |
| Cholody, WM; Kosakowska-Cholody, T; Michejda, CJ | 1 |
| Lamprecht, SA; Mokady, E; Schwartz, B; Shany, S | 1 |
| Hellot, MF; Hemet, J; Le Pessot, F; Lemoine, F; Michel, P; Paillot, B; Paresy, M; Peillon, C; Scotte, M | 1 |
| Hardwick, JC; Offerhaus, GJ; Peppelenbosch, MP; Van Den Brink, GR; Van Deventer, SJ | 1 |
| Hideshima, K; Inokuchi, T; Irie, A; Sano, K; Sekine, J; Uehara, M | 1 |
| Becker, I; Berger, U; Fink, U; Gilbertz, KP; Mueller, J; Sendler, A; Siewert, JR; van Beuningen, D | 1 |
| Calbó, J; Cascalló, M; Fueyo, J; Gelpí, JL; Marotta, M; Mazo, A; Roig, JM | 1 |
| Fisher, GH; Klimstra, D; Koretsky, A; Lenczowski, JM; Lizak, MJ; Tichelaar, JW; Varmus, HE; Wellen, SL; Whitsett, JA | 1 |
| Carreiras, F; Cruet-Hennequart, S; Gauduchon, P; Luis, J; Maubant, S; Poulain, L; Sichel, F; Staedel, C | 1 |
| Bucana, CD; Davies, MA; Dong, Z; Gallick, GE; Kim, SJ; Parikh, NU | 1 |
| Doljanski, F; Katzav, S; Markson, Y; Weiss, DW | 1 |
| Arya, SK; Carter, WA; Chawda, R; Horoszewicz, JS; Job, L | 1 |
| Huang, HX | 1 |
| Harada, M; Nakamura, Y; Nemoto, R; Shimizu, A | 1 |
| Bastian, G; Demarcq, C; Remvikos, Y | 1 |
| Anisimov, VN | 1 |
| Chung, YS; Kondo, Y; Kubo, T; Nakata, B; Satake, K; Sawada, T; Sowa, M; Yokomatsu, H | 1 |
| Takegawa, S | 1 |
| Iwasaki, Y; Ohara, K; Orii, K; Otsu, H; Sarashina, H; Todoroki, T | 1 |
| Hayashi, H; Nakanishi, I; Ooi, A | 1 |
| Nose, T; Owada, T; Shirai, S; Takano, S; Yoshii, Y | 1 |
| Kubota, Y; Moto-o, N; Nishimura, N; Saito, S; Taguchi, K; Tanaka, M; Watanabe, A; Yamazaki, K | 1 |
| Dutrillaux, B; Gerbault-Seureau, M; Prieur, M; Zafrani, B | 1 |
| Araya, JC; de Aretxabala, X; Nakamura, K; Roa, I; Saito, K; Villaseca, M; Wistuba, I | 1 |
| Hanyu, F; Kobayashi, S; Shinomiya, N; Takasaki, T; Tsugita, M; Tsuru, S | 1 |
| Bokhari, J; Hyams, D; Khan, S; Raza, A; Sheikh, Y; Yousuf, N | 1 |
| Kamma, H; Ogata, T; Ohara, K; Okumura, T; Orii, K; Sarashina, H; Sugahara, S; Tatsuzaki, H; Todoroki, T; Yoshida, T | 1 |
| Rew, DA; Taylor, I; Weaver, PC; Wilson, GD | 1 |
| Bertone, A; Candelaresi, G; Coverlizza, S; Lipkin, M; Risio, M; Rossini, FP | 1 |
| Inoue, YK; Kimura, T; Nishibe, Y | 1 |
| De Clercq, E; Iigo, M; Miwa, M | 1 |
| Goehde, W; Hemmer, J; Mauro, F; Salvati, F; Storniello, G; Teodori, L; Trinca, ML | 1 |
| Harada, M; Hattori, K; Koiso, K; Nemoto, R; Nishijima, Y; Shimazui, T; Uchida, K | 1 |
| Kagabu, T; Nishijima, M; Nishiya, I; Saito, S | 1 |
| Einhorn, N; Sahni, K; Tribukait, B | 1 |
| Hosokawa, Y; Isetani, K; Maruyama, K; Mitsufuji, S; Suzuki, G; Takanashi, T; Tani, T; Tokita, K; Tsuchihashi, Y; Yorioka, S | 1 |
| De Clercq, E; Hoshi, A; Iigo, M; Nakajima, Y; Nishikata, K; Odagiri, H; Okudaira, N | 1 |
| Hayata, Y; Morinaga, S; Shimosato, Y; Yoshida, K | 1 |
| Fujikane, T; Ishida, S; Ohsaki, Y; Onodera, S; Shimizu, T; Tsuji, T | 1 |
| Asamura, H; Shimosato, Y; Yoshida, K | 1 |
| Yoshinouchi, M | 1 |
| Cho, EK; Chung, CH; Lee, SS; Lee, TS; Park, JS | 1 |
| Harada, M; Hattori, K; Koiso, K; Nemoto, R; Shimazui, T; Uchida, K | 1 |
| Asamura, H; Mukai, K; Nakajima, T; Noguchi, M; Shimosato, Y; Yoshida, K | 1 |
| Brugnatelli, S; Buttini, R; Danova, M; Dionigi, P; Fiocca, R; Giordano, M; Giordano, P; Girino, M; Riccardi, A; Villani, L | 1 |
| De Clercq, E; Hoshi, A; Iigo, M; Nishimura, S; Yamaizumi, Z | 1 |
| De Clercq, E; Hoshi, A; Iigo, M; Nakajima, Y | 1 |
| Izutsu, T; Kagabu, T; Kaneko, S; Matsuda, M; Nishiya, I; Yoshizaki, A | 1 |
| Candelaresi, GL; Coverlizza, S; Ferrari, A; Risio, M; Rossini, FP | 1 |
| Araki, E; De Clercq, E; Hoshi, A; Iigo, M; Nakajima, Y | 1 |
| Cho, KG; Hoshino, T; Nomura, K; Pitts, LH; Shimosato, Y | 1 |
| Matsumura, K; Sasaki, K; Shinozaki, F; Takahashi, M; Tsuji, T | 1 |
| Kärcher, H; Kärcher, KH; McNally, NJ; Pfragner, R; Wilson, G | 1 |
| Lieber, MM; Sherr, CJ; Todaro, GJ | 1 |
| Clarkson, BD; Duschinsky, R; Keller, O; Krakoff, IH; La Sala, E; Van Dyk, JJ | 1 |
| Koyama, Y; Matsutani, M; Sing, OK; Takakura, K | 1 |
| Kucera, LS; Simonson, J | 1 |
| Davidson, RL; Latt, SA; Lin, MS | 1 |
| Gittes, RF; Sato, G; Schroeder, FH | 1 |
1 review(s) available for bromodeoxyuridine and Adenocarcinoma
| Article | Year |
|---|---|
Central nervous system metastasis from gallbladder carcinoma--case report.
Topics: Adenocarcinoma; Aged; Brain Neoplasms; Bromodeoxyuridine; Cisplatin; Combined Modality Therapy; Dexamethasone; Female; Frontal Lobe; Gallbladder Neoplasms; Humans; Incidence; Survival Rate | 1991 |
4 trial(s) available for bromodeoxyuridine and Adenocarcinoma
| Article | Year |
|---|---|
RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bromodeoxyuridine; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation, Preclinical; Female; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Male; Middle Aged; Models, Molecular; Molecular Chaperones; Pancreatic Neoplasms; Pilot Projects; Placebos; Rats; Rats, Sprague-Dawley; Sarcoma; Survival Analysis | 2011 |
Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Brachytherapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Confidence Intervals; Disease-Free Survival; DNA, Neoplasm; Female; Flow Cytometry; Follow-Up Studies; Humans; Kinetics; Middle Aged; Mitotic Index; Neoplasm Staging; Prospective Studies; Quality Assurance, Health Care; Radiography; Radiotherapy; Radiotherapy Dosage; Regression Analysis; S Phase; Survival Rate; Time Factors; Treatment Failure; Uterine Neoplasms | 1995 |
Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: a phase I and drug incorporation study.
Topics: Adenocarcinoma; Adult; Aged; Biopsy; Brachytherapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Humans; Intestinal Mucosa; Middle Aged; Neoplasm Recurrence, Local; Radiation-Sensitizing Agents; Radiotherapy Dosage; Survival Rate; Uterine Cervical Neoplasms | 1999 |
Pre-operative kinetic parameter determination of colorectal adenocarcinomas. Prognostic significance.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Biopsy; Bromodeoxyuridine; Colon; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Flow Cytometry; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Ploidies; Predictive Value of Tests; Prognosis; Proportional Hazards Models; S Phase | 2000 |
130 other study(ies) available for bromodeoxyuridine and Adenocarcinoma
| Article | Year |
|---|---|
Laser-induced drug release for local tumor control--a proof of concept.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; beta-Cyclodextrins; Bromodeoxyuridine; Cell Line, Tumor; Dimerization; Drug Delivery Systems; Fibroblasts; Flow Cytometry; Fluorouracil; Hydrophobic and Hydrophilic Interactions; Lasers; Palliative Care; Pancreatic Neoplasms; Solubility; Stents | 2014 |
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.
Topics: Adenocarcinoma; Animals; Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Disease Models, Animal; Fatty Acid Synthase, Type I; Flow Cytometry; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunoblotting; Immunohistochemistry; Male; Mice; Mice, Transgenic; Oncogenes; Orchiectomy; Prostatic Neoplasms; RNA, Small Interfering; Transplantation, Heterologous; Up-Regulation | 2009 |
Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Blotting, Western; Bromodeoxyuridine; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression; Gene Knockdown Techniques; Hedgehog Proteins; Humans; Inhibitory Concentration 50; Kruppel-Like Transcription Factors; Membrane Potential, Mitochondrial; Nerve Tissue Proteins; Pancreatic Neoplasms; Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; Veratrum Alkaloids; Zinc Finger Protein Gli3 | 2010 |
Gender-related differences in repopulation and early tumor response to preoperative radiotherapy in rectal cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Bromodeoxyuridine; Cell Proliferation; Dose Fractionation, Radiation; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoadjuvant Therapy; Rectal Neoplasms; S Phase; Sex Factors; Treatment Outcome | 2011 |
S100B promotes the proliferation, migration and invasion of specific brain metastatic lung adenocarcinoma cell line.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; bcl-X Protein; Blotting, Western; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lung Neoplasms; Neoplasm Invasiveness; Nerve Growth Factors; RNA, Small Interfering; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Transfection | 2011 |
Organ differences in the impact of p27(kip1) deficiency on carcinogenesis induced by N-methyl-N-nitrosourea.
Topics: Adenocarcinoma; Alkylating Agents; Animals; Antimetabolites; Body Weight; Bromodeoxyuridine; Carcinogens; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p27; Genotype; Immunohistochemistry; Lymphoma; Male; Methylnitrosourea; Mice; Mice, Knockout; Neoplasms; Organ Size; Organ Specificity | 2013 |
G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity.
Topics: Adenocarcinoma; Antimetabolites; Antimetabolites, Antineoplastic; Breast Neoplasms; Bromodeoxyuridine; Coloring Agents; Female; Flow Cytometry; Fluorouracil; G1 Phase; Head and Neck Neoplasms; Humans; Pancreatic Neoplasms; Propidium; Resting Phase, Cell Cycle; S Phase; Tumor Cells, Cultured | 2002 |
Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Female; Indicators and Reagents; Mice; Mice, Inbred CBA; Radiation-Sensitizing Agents; Rectum | 2002 |
Clinical outcome and bromodeoxyuridine derived proliferation indices in 100 colonic and rectal carcinomas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Cell Differentiation; Cell Movement; Cohort Studies; Colonic Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neoplasms, Multiple Primary; Predictive Value of Tests; Rectal Neoplasms; Staining and Labeling; Treatment Outcome | 2002 |
The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells.
Topics: Adenocarcinoma; Benzhydryl Compounds; Bromodeoxyuridine; Cell Division; Cell Nucleus; Dihydrotestosterone; Dose-Response Relationship, Drug; Estrogens, Non-Steroidal; Flow Cytometry; Genes, Reporter; Humans; Immunoblotting; Kinetics; Male; Phenols; Plasmids; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Tumor Cells, Cultured | 2002 |
GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice.
Topics: Adenocarcinoma; Animals; B-Lymphocytes; Body Weight; Bromodeoxyuridine; Cell Division; Cell Survival; Colonic Neoplasms; Genetic Vectors; Green Fluorescent Proteins; Humans; Immunocompetence; Liver Neoplasms; Luminescent Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, SCID; Microscopy, Fluorescence; T-Lymphocytes; Transfection | 2003 |
Enhancement of colon carcinogenesis by prostaglandin E2 administration.
Topics: Adenocarcinoma; Animals; Apoptosis; Azoxymethane; Bromodeoxyuridine; Carcinogens; Colon; Colonic Neoplasms; Dinoprostone; Disease Progression; DNA Primers; Incidence; Injections, Intraperitoneal; Intestinal Mucosa; Male; Rats; Rats, Inbred F344; Receptors, Prostaglandin E; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
NB1011 induces Ser15 phosphorylation of p53 and activates the G2/M checkpoint.
Topics: Adenocarcinoma; Breast Neoplasms; Bromodeoxyuridine; Colonic Neoplasms; Humans; Phosphorylation; Thymidylate Synthase; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |
Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Apoptosis; Bromodeoxyuridine; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cell Division; Disease-Free Survival; Female; Flow Cytometry; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prospective Studies; Radiation-Sensitizing Agents; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Ethylene diamine tetraacetic acid-induced colonic crypt cell proliferation in rats.
Topics: Adenocarcinoma; Adenoma; Animals; Bromodeoxyuridine; Cell Division; Chelating Agents; Colon; Colorectal Neoplasms; Disease Models, Animal; Edetic Acid; Male; Rats; Rats, Wistar | 2004 |
Inhibition of DNA methyltransferase by antisense oligodeoxynucleotide modifies cell characteristics in gastric cancer cell lines.
Topics: Adenocarcinoma; Animals; Base Sequence; Blotting, Western; Bromodeoxyuridine; Cadherins; Cell Adhesion; Cell Division; Cell Line, Tumor; Cyclin D1; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Dose-Response Relationship, Drug; Fibroblasts; Humans; Immunohistochemistry; Mice; Mice, Nude; Molecular Sequence Data; Neoplasm Invasiveness; Oligonucleotides, Antisense; Proliferating Cell Nuclear Antigen; Signal Transduction; Stomach Neoplasms; Time Factors | 2004 |
Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line.
Topics: Adenocarcinoma; Annexin A5; Antimetabolites; Apoptosis; Barrett Esophagus; Bile Acids and Salts; Blotting, Western; Bromodeoxyuridine; Cell Count; Cell Line; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophagus; Humans; In Situ Nick-End Labeling; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation | 2006 |
Three-dimensional analysis of isolated hexosaminidase-altered aberrant crypts from colons of 1,2-dimethylhydrazine-treated rats.
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Animals; beta-N-Acetylhexosaminidases; Biomarkers, Tumor; Bromodeoxyuridine; Colon; Colonic Neoplasms; Intestinal Mucosa; Male; Microscopy, Electron, Scanning; Precancerous Conditions; Rats; Rats, Inbred F344 | 2006 |
Immunohistochemical identification method of tumour cells in the S phase of mitotic cycle and its usefulness in diagnostics of mammary gland adenocarcinomas in bitches.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Division; Dog Diseases; Dogs; Female; Immunohistochemistry; Ki-67 Antigen; Mammary Neoplasms, Animal; Mitosis; Proliferating Cell Nuclear Antigen; S Phase | 2006 |
The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Azoxymethane; Biomarkers, Tumor; Bromodeoxyuridine; Carcinogens; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cyclin A; Cyclin A2; Cyclin B; Cyclin B1; Dextran Sulfate; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Neoplasm Proteins; Neoplasms, Experimental; Polymerase Chain Reaction; Proteins; Repressor Proteins; RNA, Neoplasm; RNA, Small Interfering; RNA, Untranslated; Survivin; TCF Transcription Factors; Transcription Factor 7-Like 2 Protein | 2007 |
Bromodeoxyuridine labeling index as an indicator of early tumor response to preoperative radiotherapy in patients with rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Bromodeoxyuridine; Cell Proliferation; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Rectal Neoplasms; S Phase | 2007 |
Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.
Topics: Adenocarcinoma; Androgens; Animals; Antigens, Polyomavirus Transforming; Apoptosis; Bromodeoxyuridine; Cell Proliferation; Disease Models, Animal; Hepatocyte Nuclear Factor 3-beta; Lymphatic Metastasis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Orchiectomy; Prostatic Neoplasms; Receptors, Androgen; Simian virus 40; Synaptophysin | 2007 |
Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
Topics: Adenocarcinoma; Animals; Anoikis; Antimetabolites; Antineoplastic Agents; Blotting, Western; Bone Marrow Cells; Bridged Bicyclo Compounds, Heterocyclic; Bromodeoxyuridine; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Data Interpretation, Statistical; Enzyme Activation; Flow Cytometry; JNK Mitogen-Activated Protein Kinases; Mice; Monocytes | 2008 |
Measurement of DNA synthesis by flow cytometry.
Topics: Adenocarcinoma; Bisbenzimidazole; Bromodeoxyuridine; Cell Line; Colonic Neoplasms; DNA; Flow Cytometry; Humans; Interphase; Mitosis; Propidium | 1981 |
Factors affecting the CEA secretion of human adenocarcinoma cell lines into the spent medium.
Topics: Adenocarcinoma; Bromodeoxyuridine; Bucladesine; Carcinoembryonic Antigen; Cell Line; Culture Media; Cyclic AMP; Dimethyl Sulfoxide; Dinoprostone; Humans; Interferon Type I; Prostaglandins E; Theophylline | 1983 |
Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-1 in formalin-fixed, paraffin-embedded prostatic cancer tissues.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Division; Formaldehyde; Frozen Sections; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Neoplasm Transplantation; Nuclear Proteins; Paraffin Embedding; Prostatectomy; Prostatic Neoplasms; Tissue Fixation; Tumor Cells, Cultured | 1995 |
Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells.
Topics: Adenocarcinoma; Adult; Aged; Base Sequence; Blotting, Western; Bromodeoxyuridine; Bronchi; Carcinoma, Squamous Cell; Cell Division; Cells, Cultured; Chemotaxis; DNA Primers; Epithelial Cells; Epithelium; Female; Fibroblasts; Hepatocyte Growth Factor; Humans; Lung Diseases; Lung Neoplasms; Lung Transplantation; Male; Middle Aged; Molecular Sequence Data; Neoplasm Invasiveness; Polymerase Chain Reaction; Proto-Oncogene Proteins c-met; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Tumor Cells, Cultured | 1995 |
A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal.
Topics: Adenocarcinoma; Androgens; Animals; Blotting, Western; Bromodeoxyuridine; Cell Division; Humans; Immunohistochemistry; Male; Molecular Weight; Nuclear Proteins; Orchiectomy; Phosphoproteins; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Regeneration; RNA, Messenger; Seminal Vesicles; Time Factors | 1993 |
Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Biomarkers, Tumor; Biopsy, Needle; Bromodeoxyuridine; Cell Division; Humans; Immunoglobulin M; Immunohistochemistry; Ki-67 Antigen; Male; Mitotic Index; Neoplasm Proteins; Neoplasm Staging; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Prostatectomy; Prostatic Neoplasms; T-Lymphocytes | 1995 |
Influence of sampling time on assessment of potential doubling time.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Rats, Inbred F344; Reproducibility of Results; S Phase; Specimen Handling; Time Factors | 1994 |
Endometrial carcinogenesis induced by concurrent oral administration of ethylenethiourea and sodium nitrite in mice.
Topics: Adenocarcinoma; Administration, Oral; Animals; Bromodeoxyuridine; Cocarcinogenesis; Endometrial Neoplasms; Estrus; Ethylenethiourea; Female; Gonadal Steroid Hormones; Immunohistochemistry; Mice; Organ Size; Ovary; Sodium Nitrite; Tumor Suppressor Protein p53; Uterus; Vagina; Vaginal Smears | 1994 |
Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression.
Topics: Adenocarcinoma; Antigens, Neoplasm; Bromodeoxyuridine; Cell Division; Humans; Male; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Prospective Studies; Prostatic Neoplasms; Random Allocation; Tumor Cells, Cultured | 1993 |
Aberrant crypt foci and colon tumors in F344 rats have similar increases in proliferative activity.
Topics: Adenocarcinoma; Animals; Azoxymethane; beta-N-Acetylhexosaminidases; Bromodeoxyuridine; Cell Division; Colon; Colonic Neoplasms; Histocytochemistry; Immunohistochemistry; Male; Rats; Rats, Inbred F344 | 1994 |
Are bioavailable glutamine and sensitivity to hydrochloric acid DNA denaturation important colorectal tumour characteristics?
Topics: Adenocarcinoma; Adenoma, Villous; Bromodeoxyuridine; Cell Differentiation; Colorectal Neoplasms; DNA, Neoplasm; Glutamine; Humans; Tumor Cells, Cultured | 1994 |
Relationships between nodal status and cell kinetics, DNA ploidy pattern and histopathology of the deeply infiltrating sites in colorectal adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Bromodeoxyuridine; Cell Differentiation; Colorectal Neoplasms; DNA, Neoplasm; Female; Humans; Kinetics; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Ploidies; S Phase | 1993 |
A flow cytometric bromodeoxyuridine/DNA analysis for cytokinetics of the pancreatic cancer cell line Capan-2 after irradiation.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Count; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Humans; Pancreatic Neoplasms; Tumor Cells, Cultured | 1993 |
Influence of aging on multi-organ carcinogenesis in rats induced by N-methyl-N-nitrosourea.
Topics: Adenocarcinoma; Aging; Animals; Bromodeoxyuridine; Deoxyguanosine; DNA; Intestinal Neoplasms; Lymphoma; Male; Methylnitrosourea; Neoplasms, Experimental; Rats; Rats, Inbred F344; Splenic Neoplasms; Thymus Neoplasms; Tongue Neoplasms | 1993 |
[Analysis of proliferative activity in gastric biopsy specimens by combined BrdU and DNA polymerase alpha immunohistochemistry].
Topics: Adenocarcinoma; Adenoma; Biopsy; Bromodeoxyuridine; Cell Division; DNA Polymerase II; Humans; Immunohistochemistry; Neoplasm Staging; S Phase; Stomach; Stomach Neoplasms; Tumor Cells, Cultured | 1993 |
The effect of castration on tumor growth rate and cell kinetics in hormone sensitive and hormone insensitive rat prostatic adenocarcinomas.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Cycle; Flow Cytometry; Male; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Tumor Cells, Cultured | 1995 |
PALA enhancement of bromodeoxyuridine incorporation into DNA increases radiation cytotoxicity to human ovarian adenocarcinoma cells.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Aspartic Acid; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Humans; Nucleotides; Ovarian Neoplasms; Phosphonoacetic Acid; Time Factors; Tumor Stem Cell Assay | 1996 |
Effect of selective and non-selective muscarinic blockade on baclofen inhibition of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
Topics: Adenocarcinoma; Animals; Atropine; Baclofen; Bromodeoxyuridine; Carcinogens; GABA Agonists; Male; Methylnitronitrosoguanidine; Muscarinic Antagonists; Neoplasms, Experimental; Pirenzepine; Rats; Rats, Wistar; Stomach Neoplasms | 1996 |
Quantitative microscopy and tumour cell proliferation.
Topics: Adenocarcinoma; Biomarkers, Tumor; Bromodeoxyuridine; Cell Cycle; Cell Transformation, Neoplastic; Cytophotometry; Humans; Ki-67 Antigen; Microscopy, Immunoelectron; Neoplasm Proteins; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
Evaluation of antiherpetic compounds using a gastric cancer cell line: pronounced activity of BVDU against herpes simplex virus replication.
Topics: Adenocarcinoma; Antiviral Agents; Bromodeoxyuridine; Colorimetry; Coloring Agents; Drug Evaluation, Preclinical; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Virus Replication | 1996 |
Nuclear protein as a prognostic factor of growth activity in prostatic adenocarcinoma.
Topics: Adenocarcinoma; Androgens; Animals; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Humans; Male; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Nuclear Proteins; Orchiectomy; Prognosis; Prostatic Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 1996 |
Growth characteristics in the initial stage of micrometastasis formation by bacterial LacZ gene-tagged rat prostatic adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; beta-Galactosidase; Bromodeoxyuridine; Cell Division; Collagen; Disease Models, Animal; Galactosides; Genes, Bacterial; Indoles; Kinetics; Lac Operon; Male; Mice; Mice, Nude; Microscopy, Electron; Neoplasm Metastasis; Prostatic Neoplasms; Rats | 1996 |
Comparison of mathematical formulas used for estimation of DNA synthesis time of bromodeoxyuridine-labelled cell populations with different proliferative characteristics.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cells, Cultured; DNA; Endometrial Neoplasms; Female; Fibroblasts; Flow Cytometry; Head and Neck Neoplasms; Humans; In Vitro Techniques; Kinetics; Lung; Mathematical Computing; Mice; Mice, Inbred BALB C; Mice, Nude; Sampling Studies; Time Factors; Tissue Transplantation; Tumor Cells, Cultured | 1996 |
Silver-stained nucleolar organizer regions in adenocarcinoma of the cervix--a light and electron microscopic study.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cervix Uteri; Epithelium; Female; Frozen Sections; Humans; Microscopy, Electron; Nucleolus Organizer Region; Paraffin Embedding; Silver Staining; Uterine Cervical Neoplasms | 1997 |
Tumour cell kinetics as prognostic factor in surgically-treated-non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Bromodeoxyuridine; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Division; Flow Cytometry; Humans; Lung Neoplasms; Middle Aged; Prognosis; S Phase; Survival Rate | 1997 |
Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Cycle; Cell Division; DNA, Neoplasm; Flow Cytometry; Hypoxia; Mice; Neoplasms, Experimental; Nitroimidazoles; Sarcoma, Experimental; Theophylline | 1998 |
Lack of C/EBP alpha gene expression results in increased DNA synthesis and an increased frequency of immortalization of freshly isolated mice [correction of rat] hepatocytes.
Topics: Adenocarcinoma; Albumins; Animals; Animals, Newborn; Blotting, Northern; Bromodeoxyuridine; Carcinoma, Hepatocellular; CCAAT-Enhancer-Binding Proteins; Cell Division; Cell Line; Cell Line, Transformed; Cell Survival; Cell Transformation, Neoplastic; Cells, Cultured; DNA; DNA-Binding Proteins; Gene Expression; Humans; Karyotyping; Liver; Liver Neoplasms; Mice; Mice, Knockout; Mice, Nude; Microscopy, Electron; Neoplasm Transplantation; Nuclear Proteins; RNA, Messenger; Tyrosine Transaminase | 1998 |
A simple method of tumour culture.
Topics: Adenocarcinoma; Breast Neoplasms; Bromodeoxyuridine; Cell Division; Colorectal Neoplasms; Culture Techniques; Female; Humans; Stromal Cells; Tumor Cells, Cultured | 1998 |
Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high-incidence area.
Topics: Adenocarcinoma; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cardia; Cell Division; China; Epithelial Cells; Esophageal Neoplasms; Esophagus; Humans; Immunohistochemistry; Incidence; Ki-67 Antigen; Proliferating Cell Nuclear Antigen; Stomach Neoplasms | 1997 |
Cell kinetic studies using a monoclonal antibody to bromodeoxyuridine.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; Cell Line; Colonic Neoplasms; DNA; DNA, Neoplasm; Flow Cytometry; Humans; Kinetics; Staining and Labeling; Tissue Fixation | 1998 |
Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites; Apoptosis; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Proto-Oncogene Proteins c-bcl-2; Transfection; Tumor Cells, Cultured | 1998 |
Comparison of flow and laser scanning cytometry for the assay of cell proliferation in human solid tumors.
Topics: Adenocarcinoma; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Ductal, Breast; DNA; Female; Flow Cytometry; Humans; Image Cytometry; Metaplasia; Stomach Neoplasms | 1998 |
Ki-67 (MIB 5) immunostaining of mouse lung tumors induced by 4-nitroquinoline 1-oxide.
Topics: 4-Nitroquinoline-1-oxide; Adenocarcinoma; Adenoma; Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinogens; Cell Count; Cell Division; Immunoenzyme Techniques; Ki-67 Antigen; Lung Neoplasms; Male; Mice; Mice, Inbred A; Recombinant Proteins | 1998 |
Morphometric analysis of bromodeoxyuridine distribution and cell density in the rat Dunning prostate tumor R3327-AT1 following treatment with radiation and/or hyperthermia.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Count; Fever; Male; Prostatic Neoplasms; Rats; Tumor Cells, Cultured | 1999 |
Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aneuploidy; Antimetabolites; Apoptosis; Biopsy; Bromodeoxyuridine; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cell Division; Diploidy; Disease Progression; Female; Flow Cytometry; Forecasting; Humans; Middle Aged; Mitosis; Neoplasm Staging; Prospective Studies; S Phase; Treatment Outcome; Uterine Cervical Neoplasms | 1999 |
Effect of radiation therapy on the potential doubling time of tumours in colorectal cancers.
Topics: Adenocarcinoma; Aneuploidy; Biopsy; Bromodeoxyuridine; Carcinoma; Cell Division; Colonic Neoplasms; Colonoscopy; Diploidy; DNA, Neoplasm; Dose Fractionation, Radiation; Flow Cytometry; Humans; Radiation-Sensitizing Agents; Radiotherapy Dosage; Rectal Neoplasms; S Phase; Time Factors | 1999 |
Expression of the cyclin D1 gene in rat colorectal aberrant crypt foci and tumors induced by azoxymethane.
Topics: Adenocarcinoma; Animals; Azoxymethane; Bromodeoxyuridine; Cell Division; Cell Nucleus; Colorectal Neoplasms; Cyclin D1; Cytoplasm; Gene Expression; Hyperplasia; Intestinal Mucosa; Male; Rats; Rats, Inbred F344; Time Factors | 1999 |
Interrelationship of proliferation and hypoxia in carcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Hypoxia; Female; Humans; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Uterine Cervical Neoplasms | 2000 |
Energy transfer between fluorescein isothiocyanate and propidium iodide--a problem in the estimation of Tpot with the bromodeoxyuridine-DNA flow cytometry technique?
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antimetabolites; Breast Neoplasms; Bromodeoxyuridine; CHO Cells; Coloring Agents; Cricetinae; DNA, Neoplasm; Energy Transfer; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; G1 Phase; G2 Phase; Humans; Propidium | 1999 |
Effect of tumor-conditioned medium on intercellular communication and proliferation of Balb/c 3T3 cells.
Topics: 3T3 Cells; Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Communication; Cell Division; Colonic Neoplasms; Culture Media, Conditioned; Fluorescent Dyes; Gap Junctions; Humans; Isoquinolines; Mice; Mice, Inbred BALB C; Tumor Cells, Cultured | 2000 |
Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer.
Topics: 3T3 Cells; Adenocarcinoma; Animals; Antiviral Agents; Bromodeoxyuridine; Colonic Neoplasms; Fibrosarcoma; Ganciclovir; Genetic Vectors; Kanamycin Kinase; Mice; Mice, Inbred C57BL; Phosphorylation; Plasmids; Recombinant Fusion Proteins; Retroviridae; Simplexvirus; Thymidine Kinase; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 2000 |
ras p21 Isoprenylation inhibition induces flat colon tumors in Wistar rats.
Topics: Adenocarcinoma; Adenoma; Analysis of Variance; Animals; Antimetabolites; Apoptosis; Azoxymethane; Blotting, Western; Bromodeoxyuridine; Carcinogens; Colonic Neoplasms; Colonic Polyps; Genes, ras; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Oncogene Protein p21(ras); Point Mutation; Pravastatin; Prevalence; Protein Prenylation; Random Allocation; Rats; Rats, Wistar | 2000 |
The expression frequency of common fragile sites and genetic predisposition to colon cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Alu Elements; Aphidicolin; Bromodeoxyuridine; Caffeine; Child; Child, Preschool; Chromosome Aberrations; Chromosome Fragile Sites; Chromosome Fragility; Chromosomes, Human; Colonic Neoplasms; Female; Gene Expression Profiling; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Humans; Lymphocytes; Male; Middle Aged; Pedigree | 2000 |
Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
Topics: Adenocarcinoma; Androgens; Animals; Bromodeoxyuridine; CDC2-CDC28 Kinases; Cell Cycle; Cell Line; Culture Media; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Cyclins; Electrophoresis, Polyacrylamide Gel; Fibroblasts; Genetic Vectors; Humans; Immunoblotting; Male; Neoplasms, Hormone-Dependent; Phosphorylation; Plasmids; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; ras Proteins; Rats; Retinoblastoma Protein; Signal Transduction; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |
Simultaneous estimation of T(G2+M), T(S), and T(pot) using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Bromodeoxyuridine; DNA, Neoplasm; Female; Flow Cytometry; G2 Phase; Halogens; Interphase; Kinetics; Male; Mammary Neoplasms, Experimental; Mice; Mitosis; Orchiectomy; Paclitaxel; Prostatic Neoplasms; Rats; S Phase; Thymidine | 2000 |
Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antiviral Agents; Arabinonucleosides; Bromodeoxyuridine; Catalysis; Cell Division; Cell Nucleus; Cladribine; Cytarabine; Deoxycytidine; Drosophila melanogaster; Gemcitabine; Humans; Inhibitory Concentration 50; Kinetics; Osteosarcoma; Pancreatic Neoplasms; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Promoter Regions, Genetic; Retroviridae; Substrate Specificity; Thymidine; Thymidine Kinase; Transduction, Genetic; Tumor Cells, Cultured | 2000 |
Timing of N-methyl-N-nitrosourea administration affects gastric carcinogenesis in Mongolian gerbils infected with Helicobacter pylori.
Topics: Adenocarcinoma; Alkylating Agents; Animals; Bromodeoxyuridine; Gastric Mucosa; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Intestines; Metaplasia; Methylnitrosourea; Stomach Neoplasms; Time Factors | 2000 |
Assay for DNA damage using immunochemical recognition and capillary electrophoresis.
Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Adenocarcinoma; Animals; Antibodies, Monoclonal; Bromodeoxyuridine; DNA Adducts; DNA Damage; DNA, Neoplasm; Electrophoresis, Capillary; Immunochemistry; Immunoglobulin G; Lung Neoplasms; Mice; Microscopy, Fluorescence; Plasmids; Sensitivity and Specificity; Skin; Tumor Cells, Cultured | 2001 |
Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation.
Topics: Adenocarcinoma; Adenoma; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Bromodeoxyuridine; Cell Division; Colorectal Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Staining and Labeling | 2001 |
Bisimidazoacridones induce a potent cytostatic effect in colon tumor cells that sensitizes them to killing by UCN-01.
Topics: Adenocarcinoma; Aminoacridines; Antimetabolites, Antineoplastic; Antineoplastic Agents; beta-Galactosidase; Bromodeoxyuridine; Caspase 3; Caspases; Cell Count; Cell Cycle; Cell Death; Cell Division; Colonic Neoplasms; Coloring Agents; Humans; Tumor Cells, Cultured | 2001 |
A protective role of dietary vitamin D3 in rat colon carcinogenesis.
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Animals; Body Weight; Bromodeoxyuridine; Calcifediol; Calcitriol; Calcium; Calcium, Dietary; Cell Division; Cholecalciferol; Colon; Colonic Neoplasms; Disease Models, Animal; Male; Random Allocation; Rats; Thymidine Kinase | 2000 |
Cell proliferation in colorectal adenocarcinomas: comparison between Ki-67 immunostaining and bromodeoxyuridine uptake detected by immunohistochemistry and flow cytometry.
Topics: Adenocarcinoma; Aged; Bromodeoxyuridine; Cell Division; Colorectal Neoplasms; Female; Flow Cytometry; Humans; Immunohistochemistry; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Male; Ploidies | 2001 |
Leptin is a growth factor for colonic epithelial cells.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Carrier Proteins; Colonic Neoplasms; Epithelium; Female; Growth Substances; Humans; Leptin; Mice; Obesity; Protein Kinases; Receptors, Cell Surface; Receptors, Leptin; Reverse Transcriptase Polymerase Chain Reaction; Thymidine; Tumor Cells, Cultured | 2001 |
Application of the membrane filter technique to bromodeoxyuridine immunochemistry for exfoliative cytology.
Topics: Adenocarcinoma; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cytological Techniques; Humans; Immunochemistry; Jaw Neoplasms; Membranes, Artificial; Mouth Neoplasms; Staining and Labeling; Tumor Cells, Cultured | 2001 |
Proliferation kinetics and prognosis in gastric cancer after resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Humans; Infusions, Intravenous; Ki-67 Antigen; Male; Middle Aged; Ploidies; Postoperative Care; Preoperative Care; Proliferating Cell Nuclear Antigen; Regression Analysis; S Phase; Stomach Neoplasms; Survival Analysis | 2001 |
Adenovirus-mediated wt-p16 reintroduction induces cell cycle arrest or apoptosis in pancreatic cancer.
Topics: Adenocarcinoma; Adenoviridae; Animals; Apoptosis; beta-Galactosidase; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Genetic Therapy; Genetic Vectors; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Transfection; Tumor Cells, Cultured | 2001 |
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
Topics: Adenocarcinoma; Adenoma; Animals; Apoptosis; Bromodeoxyuridine; Cyclin-Dependent Kinase Inhibitor p16; DNA Primers; Gene Expression Regulation, Neoplastic; Genes, ras; Genes, Tumor Suppressor; Genotype; In Situ Nick-End Labeling; Lung Neoplasms; Mice; Mice, Knockout; Mice, Transgenic; Models, Genetic; Neoplasm Recurrence, Local; Reverse Transcriptase Polymerase Chain Reaction; Tetracycline; Transgenes; Tumor Suppressor Protein p53 | 2001 |
Altered adhesion properties and alphav integrin expression in a cisplatin-resistant human ovarian carcinoma cell line.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antineoplastic Agents; Bromodeoxyuridine; Cell Adhesion; Cell Division; Cisplatin; DNA, Neoplasm; Drug Resistance, Neoplasm; Female; Flow Cytometry; Fluorescent Antibody Technique; Humans; Integrins; Ovarian Neoplasms; Receptors, Vitronectin; Tumor Cells, Cultured | 2002 |
Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells.
Topics: Adenocarcinoma; Adenoviridae; Animals; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Division; Genes, Tumor Suppressor; Genetic Therapy; Humans; In Situ Nick-End Labeling; Lymphatic Metastasis; Male; Mice; Mice, Nude; Neoplasm Transplantation; Phosphoric Monoester Hydrolases; Prostatic Neoplasms; PTEN Phosphohydrolase; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2002 |
Studies on effector cell-target cell interactions in vitro by means of the quantitative immunoadherence technique.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Bromodeoxyuridine; Cell Adhesion; Chickens; Cytotoxicity Tests, Immunologic; Epitopes; Immune Adherence Reaction; Immunity, Cellular; Lymphocytes; Mice; Neoplasm Transplantation; Neoplasms; Sarcoma, Avian; Spleen; Transplantation, Homologous | 1976 |
Effect of bromodeoxyuridine and interferon on cellular and viral functions in human prostatic cells.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Line; DNA, Viral; Humans; Inclusion Bodies, Viral; Interferons; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Retroviridae | 1979 |
[Agyrophilic nucleolar organizer region counts as related to bromodeoxyuridine incorporation scores in ovarian clear cell carcinoma cells].
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Cycle; Female; Humans; Nucleolus Organizer Region; Ovarian Neoplasms; Silver; Staining and Labeling; Tumor Cells, Cultured | 1992 |
Role of the vertebral venous system in metastatic spread of cancer cells to the bone.
Topics: Adenocarcinoma; Animals; Bone Marrow; Bone Neoplasms; Bromodeoxyuridine; Constriction; Epidural Space; Humans; Incidence; Lung; Male; Mice; Mice, Inbred C3H; Mice, Inbred ICR; Mice, Nude; Neoplasm Transplantation; Neoplastic Cells, Circulating; Osteosarcoma; Prostatic Neoplasms; Spine; Tail; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Veins; Vena Cava, Inferior | 1992 |
BrdUrd/DNA flow cytometry analysis demonstrates cis-diamminedichloroplatinum (II)-induced multiple cell-cycle modifications on human lung carcinoma cells.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Cycle; Cisplatin; DNA Damage; DNA, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Lung Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1992 |
Two-step carcinogenesis induced by neonatal exposure to 5-bromo-2'- deoxyuridine and subsequent administration of urethan in BALB/c mice.
Topics: Adenocarcinoma; Adenoma; Animals; Animals, Newborn; Body Weight; Bromodeoxyuridine; Cocarcinogenesis; Female; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Organ Size; Urethane | 1992 |
Flow cytometric bromodeoxyuridine/DNA analysis of hyperthermia and/or adriamycin for human pancreatic adenocarcinoma cell line Capan-2.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Count; Cell Cycle; Cell Survival; Combined Modality Therapy; Culture Techniques; DNA, Neoplasm; Doxorubicin; Flow Cytometry; Humans; Hyperthermia, Induced; Pancreatic Neoplasms; Tumor Cells, Cultured | 1992 |
[Correlation of DNA index and BrdU labeling index with clinicopathological factors in colorectal carcinoma].
Topics: Adenocarcinoma; Bromodeoxyuridine; Chi-Square Distribution; Colorectal Neoplasms; DNA, Neoplasm; Flow Cytometry; Humans; Lymphatic Metastasis; Neoplasm Staging; Ploidies | 1992 |
Effects of preoperative radiotherapy on rectal cancer. Preliminary report on combining radiation with intratumor injections of peplomycin and bromodeoxyuridine.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bromodeoxyuridine; Clinical Protocols; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Peplomycin; Preoperative Care; Radiotherapy Dosage; Rectal Neoplasms; Survival Rate | 1990 |
Biological and clinicopathological significance of endocrine differentiation of gastric adenocarcinoma evaluated by double immunohistochemical labeling for chromogranin A and bromodeoxyuridine.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Differentiation; Cell Division; Chromogranin A; Chromogranins; Gastrins; Glicentin; Glucagon; Glucagon-Like Peptides; Glycoprotein Hormones, alpha Subunit; Hormones; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Peptide Fragments; Protein Precursors; Serotonin; Somatostatin; Stomach Neoplasms | 1990 |
Cell-kinetic analysis of pancreatic cancers in Syrian golden hamsters.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Cycle; Cricetinae; Female; Immunohistochemistry; Kinetics; Male; Mesocricetus; Neoplasm Transplantation; Nitrosamines; Pancreatic Neoplasms; Tumor Cells, Cultured | 1991 |
Prolonged G2 phase of breast cancer cells and chromosome damage.
Topics: Adenocarcinoma; Breast Neoplasms; Bromodeoxyuridine; Chromosome Aberrations; Chromosome Banding; Chromosomes; Female; G2 Phase; Humans; Karyotyping; Time Factors; Tumor Cells, Cultured | 1991 |
[Advanced stomach neoplasms: expression of the fixation index of bromodeoxyuridine in vivo].
Topics: Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; Biopsy; Bromodeoxyuridine; DNA, Neoplasm; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Stomach Neoplasms; Tissue Fixation | 1991 |
Flowcytometric measurement of the cell cycle of experimental tumors: some devices for accurate measurement of proliferative activity.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Cycle; Cell Division; DNA, Neoplasm; Flow Cytometry; Lymphoma; Mice; Mice, Inbred C57BL | 1991 |
Cell cycle parameters and DNA ploidy in colorectal carcinomas.
Topics: Adenocarcinoma; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Cycle; Colorectal Neoplasms; DNA; Humans; Idoxuridine; Pilot Projects; Ploidies; S Phase; Time Factors | 1991 |
[Histopathological evaluation of the radiosensitizing effects of an intratumoral injection of BrdU for rectal cancer].
Topics: Adenocarcinoma; Bromodeoxyuridine; Combined Modality Therapy; Female; Humans; Injections, Intralesional; Male; Middle Aged; Radiation-Sensitizing Agents; Rectal Neoplasms | 1991 |
Proliferation characteristics of human colorectal carcinomas measured in vivo.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aneuploidy; Bromodeoxyuridine; Cell Cycle; Colonic Neoplasms; Diploidy; DNA, Neoplasm; Female; Flow Cytometry; Humans; Male; Middle Aged; Mitosis; Rectal Neoplasms; S Phase | 1991 |
Correlations between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine.
Topics: Adenocarcinoma; Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Bromodeoxyuridine; Cell Division; Colorectal Neoplasms; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Pathology; Rectum | 1991 |
5-Bromodeoxyuridine enhancement of Inoue-Melnick virus synthesis in human colon carcinoma cell lines.
Topics: Adenocarcinoma; Bromodeoxyuridine; Colonic Neoplasms; Humans; Tumor Cells, Cultured; Virus Replication; Viruses | 1990 |
Optimal treatment regimens for 5'-deoxy-5-fluorouridine, with or without (E)-5-(2-bromovinyl)-2'-deoxyuridine, against various tumors in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antiviral Agents; Bromodeoxyuridine; Colonic Neoplasms; Drug Therapy, Combination; Floxuridine; Fluorouracil; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Pentosyltransferases; Prodrugs; Pyrimidine Phosphorylases | 1990 |
Cytokinetic investigation of lung tumors using the anti-bromodeoxyuridine (BUdR) monoclonal antibody method: comparison with DNA flow cytometric data.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Interphase; Lung Neoplasms; Neoplasm Proteins; Tumor Cells, Cultured | 1990 |
S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; Humans; Immunoenzyme Techniques; Male; Prognosis; Prostatic Neoplasms | 1990 |
[Quenching effect and analysis of cell proliferation in dual-laser flow cytometry with human endometrial adenocarcinoma cells in vitro].
Topics: Adenocarcinoma; Benzimidazoles; Bromodeoxyuridine; Butyrates; Butyric Acid; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Gene Expression; Humans; Interphase; Lasers; Tumor Cells, Cultured; Uterine Neoplasms | 1990 |
Development of ploidy and cell proliferation in serial samples of ascites from patients with ovarian carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Ascites; Bromodeoxyuridine; Cell Division; Endometriosis; Female; Flow Cytometry; Follow-Up Studies; Humans; Interphase; Middle Aged; Ovarian Neoplasms; Ploidies | 1990 |
[Cell proliferation in a triple gastric cancer--a study using the isolated organ perfusion system].
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Blood Substitutes; Bromodeoxyuridine; Cell Division; Humans; Immunohistochemistry; In Vitro Techniques; Male; Neoplasms, Multiple Primary; Perfusion; Stomach Neoplasms | 1990 |
Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5'-deoxy-5-fluorouridine against adenocarcinoma 755 in mice. Correlation with pharmacokinetics of plasma 5-fluorouracil levels.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bromodeoxyuridine; Chromatography, High Pressure Liquid; Drug Synergism; Floxuridine; Fluorouracil; Half-Life; Male; Mice; Neoplasm Transplantation; Spectrophotometry, Ultraviolet | 1989 |
A cell kinetic study of pulmonary adenocarcinoma by an immunoperoxidase procedure after bromodeoxyuridine labeling.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Division; Cell Nucleus; Female; Humans; Immunoenzyme Techniques; Kinetics; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitotic Index | 1989 |
Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Cycle; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Cisplatin; DNA, Neoplasm; Flow Cytometry; Humans; Kinetics; Lung Neoplasms; Tumor Cells, Cultured | 1989 |
[The degree of malignancy in lung adenocarcinoma and related factors-- nuclear DNA content and bromodeoxyuridine labeling index].
Topics: Adenocarcinoma; Aneuploidy; Bromodeoxyuridine; Cell Differentiation; Cell Nucleus; DNA, Neoplasm; Humans; Lung Neoplasms; Neoplastic Stem Cells; Prognosis; Prospective Studies | 1989 |
[Immunohistochemical approach to reveal the growth potential of uterine cancers using anti-BrdU antibody and Ki-67].
Topics: Adenocarcinoma; Antibodies, Monoclonal; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Nucleus; Female; Humans; Immunohistochemistry; Mitotic Index; Uterine Cervical Neoplasms; Uterine Neoplasms | 1989 |
In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Nucleus; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Vitro Techniques; Interphase; Lymphoma; Neoplasms | 1989 |
Immunocytochemical demonstration of S phase cells by anti-bromodeoxyuridine monoclonal antibody in human prostate adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Humans; Immunoenzyme Techniques; Interphase; Male; Middle Aged; Prostate; Prostatic Neoplasms | 1989 |
Factors possibly affecting the degree of malignancy in adenocarcinoma of the lung. DNA content and bromodeoxyuridine (BrdU) labeling index.
Topics: Adenocarcinoma; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Humans; Lung Neoplasms; Prognosis | 1989 |
In vivo bromodeoxyuridine incorporation in human gastric cancer: a study on formalin-fixed and paraffin-embedded sections.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Bromodeoxyuridine; Formaldehyde; Humans; Immunoenzyme Techniques; Paraffin; Stomach Neoplasms | 1988 |
The antitumor potency of oral tegafur against adenocarcinoma 755 in mice is markedly enhanced by oral (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Drug Synergism; Metabolic Clearance Rate; Mice; Neoplasms, Experimental; Tegafur | 1987 |
Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil and ftorafur against adenocarcinoma 755 in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cysteine; Drug Evaluation, Preclinical; Drug Synergism; Fluorouracil; Male; Mice; Tegafur | 1987 |
Appreciation for malignancy on ovarian neoplasm by monoclonal antibody of BrdUrd.
Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Bromodeoxyuridine; Cystadenocarcinoma; DNA, Neoplasm; Female; Flow Cytometry; Humans; Immunohistochemistry; Middle Aged; Ovarian Neoplasms; Teratoma | 1988 |
Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel.
Topics: Adenocarcinoma; Adenoma; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Division; Colonic Neoplasms; Colonic Polyps; Epithelial Cells; Female; Humans; Immunohistochemistry; Intestinal Mucosa; Intestinal Polyps; Male; Rectal Neoplasms | 1988 |
Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil against adenocarcinoma 755 in mice. Increased therapeutic index and correlation with increased plasma 5-fluorouracil levels.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Chromatography, High Pressure Liquid; Drug Synergism; Fluorouracil; Male; Mice | 1988 |
Proliferative potential of brain metastases.
Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Carcinoma; Cell Division; Female; Humans; Interphase; Male; Middle Aged; Mitotic Index | 1988 |
Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors.
Topics: Adenocarcinoma; Antigens; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Humans; Neoplasms; Nuclear Proteins | 1988 |
[Flow cytometric measurements of in vivo incorporated bromodeoxy- uridine into the DNA of experimental and human tumors].
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Bromodeoxyuridine; DNA, Neoplasm; Flow Cytometry; Humans; Mice; Neoplasms, Experimental | 1985 |
S-tropic murine type-C viruses: frequency of isolation from continuous cell lines, leukemia virus preparations and normal spleens.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Animals; Bromodeoxyuridine; Cell Line; Clone Cells; Connective Tissue; Female; Gammaretrovirus; Goats; Leukemia; Liver; Melanoma; Mice; Mice, Inbred Strains; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Radioimmunoassay; Rauscher Virus; Retroviridae; RNA-Directed DNA Polymerase; Sarcoma 180; Spleen; Tritium; Virus Cultivation | 1974 |
Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
Topics: Adenocarcinoma; Adult; Aged; Animals; Bromodeoxyuridine; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Colonic Neoplasms; Deoxyuridine; Dogs; Female; Floxuridine; Gallbladder Neoplasms; Gastrointestinal Neoplasms; Humans; Ileocecal Valve; Intestinal Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Rectal Neoplasms; Sarcoma; Stomach Neoplasms | 1967 |
[Treatment of malignant brain tumors by the intrathecal administration of BAR (EUdR-antimetabolite-radiation)].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites; Brain Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Child; Child, Preschool; Ependymoma; Female; Glioblastoma; Humans; Injections, Spinal; Male; Medulloblastoma; Meningioma; Methotrexate; Middle Aged; Mitomycins; Pinealoma; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Retinoblastoma | 1972 |
Isolation and characterization of a cell line from the cocultivation of Lucké renal tumor cells and nontransformed feeder cells.
Topics: Adenocarcinoma; Animals; Anterior Chamber; Anura; Bromodeoxyuridine; Cell Division; Cell Line; Cytoplasm; Herpesviridae; Idoxuridine; Inclusion Bodies; Karyotyping; Kidney Neoplasms; Microscopy, Electron; Neoplasm Transplantation; Rana pipiens; Tongue; Transplantation, Homologous; Virus Replication | 1974 |
Microfluorometric detection of asymmetry in the centromeric region of mouse chromosomes.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Line; Chromosomes; DNA; DNA Replication; Fluorescent Dyes; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Thymidine | 1974 |
Human prostatic adenocarcinoma: growth in monolayer tissue culture.
Topics: Acid Phosphatase; Adenocarcinoma; Androgens; Animals; Bromodeoxyuridine; Cell Division; Culture Media; Culture Techniques; DNA, Neoplasm; Dogs; Epithelium; Fibroblasts; Humans; Light; Male; Microscopy, Phase-Contrast; Prostatic Neoplasms; Zinc | 1971 |